BioSpace News Archive

Business

Viridian Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Updates

Viridian Therapeutics, Inc. announced financial results for the first quarter ending March 31, 2022 and provided corporate updates, including interim results for the healthy volunteer portion of the Company’s ongoing proof of concept trial of VRDN-001 in Thyroid Eye Disease.

May 12, 2022
·
12 min read
Business

IntelGenx Reports First Quarter 2022 Financial Results

IntelGenx Technologies Corp. reported financial results for the first quarter ended March 31, 2022.

May 12, 2022
·
5 min read
Business

Diffusion Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

Diffusion Pharmaceuticals Inc., a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, announced financial results for the quarter ended March 31, 2022, and provided a business update.

May 12, 2022
·
7 min read
Drug Development

CANbridge to Present CAN106 Phase 1 Data at the European Hematology Association 2022 Congress

CANbridge Pharmaceuticals, Inc. (HKEX:1228), announced that data from its CAN106 Phase 1 trial will be presented at the 2022 European Hematology Association Congress, in Vienna, Austria, on June 10th.

May 12, 2022
·
2 min read
Genetown

Agios to Present Clinical and Translational Data at the European Hematology Association Annual Congress

Agios Pharmaceuticals, Inc. announced that clinical and translational data will be presented at the European Hematology Association Annual Congress, hosted virtually and in person in Vienna on June 9-12, 2022.

May 12, 2022
·
10 min read
Drug Development

Cogent Biosciences Announces Presentation at European Hematology Association (EHA) Annual Congress

Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, announced a poster presentation at the European Hematology Association Congress being held June 9-12, 2022.

May 12, 2022
·
1 min read
Biotech Bay

GBT Announces Five Data Presentations on Sickle Cell Disease at Upcoming EHA2022 Congress

Global Blood Therapeutics, Inc. announced five abstracts related to its sickle cell disease programs will be presented at the European Hematology Association 2022 Hybrid Congress.

May 12, 2022
·
14 min read
Biotech Bay

Caribou Biosciences Announces Positive Initial Data for CB-010 Anti-CD19 Allogeneic CAR-T Cell Therapy

Caribou Biosciences, Inc. announced initial results demonstrating a 100% overall response rate and 80% complete response rate in cohort 1 from its ANTLER Phase 1 trial for CB-010 in patients with relapsed or refractory B cell non-Hodgkin lymphoma.

May 12, 2022
·
9 min read
Drug Development

Wugen to Present Preclinical Data on WU-NK-101 at the European Hematology Association (EHA) 2022 Hybrid Congress

Wugen, Inc. announced it will present new preclinical data highlighting the anti-tumor activity of Wugen’s lead memory natural killer product candidate WU-NK-101 at the European Hematology Association 2022 Hybrid Congress being held June 9-12, 2022, virtually and in-person in Vienna, Austria.

May 12, 2022
·
2 min read
Genetown

Ultivue Announces AI Partner Ecosystem to Accelerate Analysis of Multiplex Immunofluorescence Image Data in Translational Medicine

Ultivue, Inc., an industry leader in multiplexing assays and analytics solutions for tissue biomarker studies, announced multiple collaborations for AI-powered spatial phenomics solutions for translational research groups and Biopharma.

May 12, 2022
·
3 min read